首页|组蛋白去乙酰化酶抑制剂Tubastatin A对大鼠急性肝损伤影响的研究

组蛋白去乙酰化酶抑制剂Tubastatin A对大鼠急性肝损伤影响的研究

扫码查看
目的 研究组蛋白去乙酰化酶抑制剂Tubastatin A对大鼠急性肝损伤的影响。方法 实验分为 3 组:正常对照组,模型组,干预组,每组各 15 只,模型组及干预组采用D-氨基半乳糖(D-GaIN)/脂多糖(LPS)诱导SD大鼠急性肝损伤模型,造模同时给予模型组 0。9%氯化钠注射液灌胃,干预组给予Tubastatin A灌胃,实验 1 周后,苏木精-伊红(HE)染色观察大鼠肝脏形态学改变,检测大鼠血清谷胺酰基转移酶(GT)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、C反应蛋白(CRP)等指标水平,蛋白印迹(Western-blot)检测肝脏组织Caspase3 及Bcl-2 的表达水平。结果 与对照组相比,模型组大鼠肝脏出现显著水肿、坏死、炎症反应等形态学改变,Tubastatin A干预可减轻肝损伤程度。与对照组相比,模型组大鼠血清ALT,AST,γ-GT,CRP,白细胞介素-6(IL-6)等指标显著上升(P<0。05),Tubastatin A干预可下调大鼠血清ALT,AST,γ-GT,CRP,IL-6等指标水平,差异有统计学意义(P<0。05)。模型组大鼠肝脏Caspase3 的表达水平升高,Bcl-2 表达水平降低。与模型组相比,干预组Caspase 3 的表达水平降低,Bcl-2 表达水平升高,差异有统计学意义(P<0。05)。结论 Tubastatin A对D-GaIN/LPS诱导的大鼠急性肝损伤具有一定的治疗作用。
Effect of histone deacetylase inhibitor Tubastatin A on acute liver injury in rats
Objective To investigate the effect of histone deacetylase inhibitor Tubastatin A on acute liver injury in rats.Methods The experimental rats were divided into three groups:normal control group,model group,and intervention group,with 15 rats in each group.The model group and intervention group were induced with D-galactosamine(D-GaIN)/lipopolysaccharide(LPS)to create an acute liver injury model in SD rats.At the same time,the model group was given physiological saline by gavage,and the intervention group was given Tubastatin A.After one week of the experiment,HE staining was used to observe the morphological changes in the rat liver,and the levels of serum glutamyl transferase(GT),aspartate aminotransferase(ALT),alanine aminotransferase(AST),C-reactive protein(CRP),and other indicators were detected.Western blot was used to detect the expression levels of Caspase3 and Bcl-2 in liver tissue.Results Compared with the control group,the model group rats showed significant morphological changes such as edema,necrosis,and inflammatory response in the liver.Tubastatin A intervention could alleviate the degree of liver injury.Compared with the control group,the serum ALT,AST,γ-GT,CRP,IL-6,and other indicators in the model group rats were significantly increased(P<0.05).Tubastatin A intervention could downregulate the levels of serum ALT,AST,γ-GT,CRP,IL-6,and other indicators in rats,and the difference was statistically significant(P<0.05).The expression level of Caspase 3 in the liver of the model group rats was significantly increased,while the expression level of Bcl-2 was significantly decreased.Compared with the model group,the intervention group showed a decrease in Caspase 3 expression level and an increase in Bcl-2 expression level,with statistical significance(P<0.05).Conclusion Tubastatin A has a certain therapeutic effect on acute liver injury induced by D-GaIN/LPS in rats.

Acute liver injuryHistone deacetylase inhibitorsTubastatin A

刘云忠、刘文操

展开 >

030001 太原,山西省人民医院急诊科

急性肝损伤 组蛋白去乙酰化酶抑制剂 Tubastatin A

2024

山西医药杂志
山西医药卫生传媒集团有限责任公司

山西医药杂志

影响因子:0.504
ISSN:0253-9926
年,卷(期):2024.53(24)